Follow
catherine s adamson
catherine s adamson
Verified email at st-andrews.ac.uk
Title
Cited by
Cited by
Year
Human immunodeficiency virus type 1 assembly, release, and maturation
CS Adamson, EO Freed
Advances in pharmacology 55, 347-387, 2007
2482007
Novel approaches to inhibiting HIV-1 replication
CS Adamson, EO Freed
Antiviral research 85 (1), 119-141, 2010
1992010
Antiviral drug discovery: preparing for the next pandemic
CS Adamson, K Chibale, RJM Goss, M Jaspars, DJ Newman, ...
Chemical Society Reviews 50 (6), 3647-3655, 2021
1852021
In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)
CS Adamson, SD Ablan, I Boeras, R Goila-Gaur, F Soheilian, ...
Journal of virology 80 (22), 10957-10971, 2006
1372006
HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice
PW Keller, CS Adamson, JB Heymann, EO Freed, AC Steven
Journal of virology 85 (4), 1420-1428, 2011
1232011
The molecular basis of HIV capsid assembly—five years of progress
CS Adamson, IM Jones
Reviews in medical virology 14 (2), 107-121, 2004
992004
Virus maturation as a new HIV-1 therapeutic target
CS Adamson, K Salzwedel, EO Freed
Expert opinion on therapeutic targets 13 (8), 895-908, 2009
972009
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV-1maturation inhibitor bevirimat
CS Adamson, M Sakalian, K Salzwedel, EO Freed
Retrovirology 7, 1-8, 2010
952010
Far-UVC (222 nm) efficiently inactivates an airborne pathogen in a room-sized chamber
E Eadie, W Hiwar, L Fletcher, E Tidswell, P O’Mahoney, M Buonanno, ...
Scientific reports 12 (1), 4373, 2022
862022
Determinants of activity of the HIV-1 maturation inhibitor PA-457
F Li, D Zoumplis, C Matallana, NR Kilgore, M Reddick, AS Yunus, ...
Virology 356 (1-2), 217-224, 2006
812006
Inhibitors of the interferon response enhance virus replication in vitro
CE Stewart, RE Randall, CS Adamson
PloS one 9 (11), e112014, 2014
772014
Protease-mediated maturation of HIV: inhibitors of protease and the maturation process
CS Adamson
Molecular biology international 2012, 2012
662012
Recent progress in antiretrovirals–lessons from resistance
CS Adamson, EO Freed
Drug discovery today 13 (9-10), 424-432, 2008
592008
Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457)
CS Adamson, K Waki, SD Ablan, K Salzwedel, EO Freed
Journal of virology 83 (10), 4884-4894, 2009
572009
Hydrazone- and Hydrazide-Containing N-Substituted Glycines as Peptoid Surrogates for Expedited Library Synthesis:  Application to the Preparation of Tsg101 …
F Liu, AG Stephen, CS Adamson, K Gousset, MJ Aman, EO Freed, ...
Organic letters 8 (22), 5165-5168, 2006
542006
Bright and early: Inhibiting human cytomegalovirus by targeting major immediate-early gene expression or protein function
CS Adamson, MM Nevels
Viruses 12 (1), 110, 2020
522020
Molecular characterization of feline immunodeficiency virus budding
BG Luttge, M Shehu-Xhilaga, DG Demirov, CS Adamson, F Soheilian, ...
Journal of virology 82 (5), 2106-2119, 2008
512008
Cloning and characterization of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrix
SA WILSON, C SIEIRO-VAZQUEZ, NJ EDWARDS, O IOURIN, ED BYLES, ...
Biochemical Journal 342 (1), 97-103, 1999
481999
Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector
S Grüschow, CS Adamson, MF White
Nucleic acids research 49 (22), 13122-13134, 2021
442021
Analysis of TYA protein regions necessary for formation of the Ty1 virus-like particle structure
JL Brookman, AJ Stott, PJ Cheeseman, CS Adamson, D Holmes, J Cole, ...
Virology 212 (1), 69-76, 1995
381995
The system can't perform the operation now. Try again later.
Articles 1–20